Type	Name	Date
Indenture	Indenture, by and among Angiotech Pharmaceuticals (US), Inc., Angiotech Pharmaceuticals, Inc., certain of its subsidiaries party thereto and Deutsche Bank National Trust Company, as trustee, for 9% Senior Notes due 2016	08/16/2012
Indenture	Supplemental Indenture, by and among Angiotech Pharmaceuticals, Inc., certain of its subsidiaries party thereto and Deutsche Bank National Trust Company, as trustee, for Senior Floating Rate Notes due 2013	08/16/2012
Credit agreement	Second Amendment to Credit Agreement, by and among Angiotech Pharmaceuticals, Inc. (“Parent”), the subsidiaries of the Parent listed as borrowers on the signature pages thereto (“Borrowers”), and Wells Fargo Capital Finance, LLC as arranger and administrative agent (“Agent”) for the lenders listed on the signature pages thereto (“Lenders”)	03/16/2012
Credit agreement	First Amendment to Credit Agreement, by and among Angiotech Pharmaceuticals, Inc., as Parent, the subsidiaries of Parent listed as borrowers on the signature pages thereto, as borrowers, as lenders and Wells Fargo Capital Finance, LLC as arranger, administrative agent and lender	07/20/2011
Credit agreement	Credit Agreement, by and among Angiotech Pharmaceuticals, Inc., as Parent, the subsidiaries of Parent listed as borrowers on the signature pages thereto, as borrowers, the lenders signatory thereto, as lenders and Wells Fargo Capital Finance, LLC as arranger and administrative agent	05/16/2011
Registration rights agreement	Registration Rights Agreement, among Angiotech Pharmaceuticals, Inc. and the investors party thereto	05/16/2011
Indenture	Indenture, by and among Angiotech Pharmaceuticals, Inc., certain of its subsidiaries party thereto and Deutsche Bank National Trust Company, as trustee, for senior secured floating rate notes due 2013	05/16/2011
Indenture	Supplemental Indenture, by and among Angiotech Pharmaceuticals, Inc., certain of its subsidiaries party thereto and Deutsche Bank National Trust Company, as trustee, for senior floating rate notes due 2013	05/16/2011
Credit agreement	Credit Agreement, among Angiotech Pharmaceuticals, Inc., certain of its subsidiaries, the lenders signatory thereto and Wells Fargo Capital Finance, LLC, as arranger and administrative agent	02/10/2011
Indenture	Supplemental Indenture, between Angiotech Pharmaceuticals, Inc. and U.S. Bank National Association, relating to the Company's senior subordinated notes	01/28/2011
Indenture	Supplemental Indenture, between Angiotech Pharmaceuticals, Inc. and U.S. Bank National Association, relating to the Company's 7.75% Subordinated Notes	11/02/2010
Credit agreement	Third Amendment to Credit Agreement, by and among Angiotech, as Parent, the subsidiaries of Parent listed as borrowers on the signature pages thereto, as borrowers, the lenders signatory thereto, as lenders, and Wells Fargo Capital Finance, LLC (f/k/a Wells Fargo Foothill, LLC), as arranger and administrative agent	04/27/2010

Type	Name	Date
Equity incentive plans	Angiotech Pharmaceuticals, Inc. 2011 Stock Incentive Plan	05/16/2011
Employment agreement	Amendment to Executive Employment Agreement with William L. Hunter, M.D	04/05/2011